BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32546362)

  • 1. Transfer of antigen-encoding bone marrow under immune-preserving conditions deletes mature antigen-specific B cells in recipients and inhibits antigen-specific antibody production.
    Brooks JF; Barber JEM; Davies JM; Wells JW; Steptoe RJ
    Cytotherapy; 2020 Aug; 22(8):436-444. PubMed ID: 32546362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor.
    Hornung RL; Longo DL; Bowersox OC; Kwak LW
    J Natl Cancer Inst; 1995 Sep; 87(17):1289-96. PubMed ID: 7544833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance.
    Bhatt KH; Rudraraju R; Brooks JF; Jung JW; Galea R; Wells JW; Steptoe RJ
    Stem Cell Res Ther; 2017 Mar; 8(1):57. PubMed ID: 28279220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance induction with gene-modified stem cells and immune-preserving conditioning in primed mice: restricting antigen to differentiated antigen-presenting cells permits efficacy.
    Coleman MA; Bridge JA; Lane SW; Dixon CM; Hill GR; Wells JW; Thomas R; Steptoe RJ
    Blood; 2013 Feb; 121(6):1049-58. PubMed ID: 23233664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
    Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
    Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
    Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
    Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological tolerance in bone marrow-derived lymphocytes. I. Evidence for an intracellular mechanism of inactivation of hapten-specific precursors of antibody-forming cells.
    Katz DH; Hamaoka T; Benacerraf B
    J Exp Med; 1972 Dec; 136(6):1404-29. PubMed ID: 4539311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An established immune response against ovalbumin is suppressed by a transferable serum factor produced after ovalbumin feeding: a role of CD25+ regulatory cells.
    Karlsson MR; Kahu H; Hanson LA; Telemo E; Dahlgren UI
    Scand J Immunol; 2002 May; 55(5):470-7. PubMed ID: 11975758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes.
    Zambidis ET; Kurup A; Scott DW
    Mol Med; 1997 Mar; 3(3):212-24. PubMed ID: 9100227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell-mediated oral tolerance is intact in germ-free mice.
    Walton KL; Galanko JA; Balfour Sartor R; Fisher NC
    Clin Exp Immunol; 2006 Mar; 143(3):503-12. PubMed ID: 16487250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of intrinsic B lymphocyte tolerance in mixed but not in complete semiallogeneic bone marrow chimeras.
    Salam A; Moodley J; Waer M
    Transplantation; 1997 Mar; 63(5):699-704. PubMed ID: 9075841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
    Porgador A; Gilboa E
    J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage.
    Franco L; Benedetti R; Ferek GA; Massouh E; Fló J
    Cell Immunol; 1998 Nov; 190(1):1-11. PubMed ID: 9826441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aire regulates the transfer of antigen from mTECs to dendritic cells for induction of thymic tolerance.
    Hubert FX; Kinkel SA; Davey GM; Phipson B; Mueller SN; Liston A; Proietto AI; Cannon PZ; Forehan S; Smyth GK; Wu L; Goodnow CC; Carbone FR; Scott HS; Heath WR
    Blood; 2011 Sep; 118(9):2462-72. PubMed ID: 21505196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance.
    Chen JC; Kuo ML; Ou LS; Chang PY; Muench MO; Shen CR; Chang HL; Yu HY; Fu RH
    Cell Transplant; 2010; 19(12):1609-22. PubMed ID: 20719075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose bone marrow transplantation induces deletion of antigen-specific T cells in a Fas-independent manner.
    Honey K; Bemelman F; Cobbold SP; Waldmann H
    Transplantation; 2000 Apr; 69(8):1676-82. PubMed ID: 10836380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin.
    Miller SD; Hanson DG
    J Immunol; 1979 Nov; 123(5):2344-50. PubMed ID: 90707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.